Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05430477 · ClinicalTrials.gov registry record
Characterizing In Vivo Oral Lesion Impedances
A clinical trial, sponsored by Ryan J. Halter.
- Completed
- Registry status
- 114
- Enrollment target
NCT05430477 is a clinical trial that has completed, run by Ryan J. Halter. The registered enrollment target is 114 participants.
The verdict
NCT05430477 has completed, sponsored by Ryan J. Halter.
- COMPLETED
- Registry status
- 114 participants
- Enrollment target
Study Summary
The primary objective of this study is to demonstrate a significant difference in electrical impedance between normal, benign, premalignant, and malignant oral lesions using a custom device. The secondary study objective is to create a database of in vivo electrical impedance spectra and images of oral lesions. This will be achieved by collecting Electrical Impedance sensing data and images from two cohorts of patients: Cohort I will consist of 200 patients undergoing oral lesion biopsies and Cohort II will be comprised of 50 patients scheduled for oral cancer resection. A maximum of 5 additional subjects will be initially enrolled in each Cohort to optimize data acquisition.
Interventions
- DEVICE Electrical impedance imaging using Non-Significant Risk device (EII probe)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2022-08-29 |
| Est. Completion | 2025-08-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05430477
The ClinicalTrials.gov registry entry for NCT05430477 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 114 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ryan J. Halter, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Electrical impedance imaging using Non-Significant Risk device (EII probe) is the first listed.
NCT05430477 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05430477 about?
NCT05430477 is a clinical study titled "Characterizing In Vivo Oral Lesion Impedances". The primary objective of this study is to demonstrate a significant difference in electrical impedance between normal, benign, premalignant, and malignant oral lesions using a custom device. The secondary study objective is to create a database of in vivo electrical impedance spectra and images of o...
What is the current status of trial NCT05430477?
This trial is currently completed. The enrollment target is 114 participants. The study started on 2022-08-29. Estimated completion is 2025-08-20.
What interventions are being tested in trial NCT05430477?
The interventions under investigation include: Electrical impedance imaging using Non-Significant Risk device (EII probe) (DEVICE).
Who is sponsoring clinical trial NCT05430477?
This trial is sponsored by Ryan J. Halter, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.